Addus HomeCare Analyst Ratings
TD Cowen Adjusts Addus HomeCare Price Target to $128 From $119, Maintains Buy Rating
Addus HomeCare Analyst Ratings
Addus HomeCare Analyst Ratings
Addus HomeCare Analyst Ratings
RBC Raises Price Target on Addus HomeCare to $129 From $102, Keeps Outperform Rating
Addus HomeCare Analyst Ratings
TD Cowen Maintains Buy on Addus HomeCare, Raises Price Target to $119
Analysts' Opinions Are Mixed on These Healthcare Stocks: Addus Homecare (ADUS), BioCryst (BCRX) and Syndax Pharmaceuticals (SNDX)
Addus Homecare (ADUS) Receives a Rating Update From a Top Analyst
Addus HomeCare Analyst Ratings
B of A Securities Maintains Buy on Addus HomeCare, Raises Price Target to $118
Addus HomeCare Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS), Telix Pharmaceuticals Ltd. (OtherTLPPF) and Intuitive Surgical (ISRG)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Addus Homecare (ADUS), Pfizer (PFE) and Cardinal Health (CAH)
Addus HomeCare Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: Dyne Therapeutics (DYN), Addus Homecare (ADUS)
Addus HomeCare Analyst Ratings
Addus HomeCare Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Addus Homecare (ADUS), Jazz Pharmaceuticals (JAZZ)